Article
The -174G/C interleukin-6 promoter polymorphism influences the development of macular oedema following uncomplicated phacoemulsification surgery.
Eye (London, England) - 1 Nov 2007
Masood I, Negi A, Vernon S A, Comeglio P, Child A H
Abstract excerpt
AIM: To determine whether the functional -174 G/C interleukin-6 gene polymorphism is a risk factor for the development of cystoid macular oedema (CMO) following routine uncomplicated phacoemulsification surgery in patients with no established risk factors. METHODS: A total of 40 patients who underwent routine phacoemulsification surgery as part of a randomised controlled trial comparing the use of postoperative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
